BRMIX
iShares Russell MidCap IxFd-Inst
Introduction to iShares Russell MidCap IxFd-Inst
The iShares Russell MidCap IxFd-Inst (BRMIX) is designed to track the performance of the Russell Midcap Index, which represents the mid-cap sector of the U.S. equity market. This fund is part of the BlackRock family and offers institutional investors a cost-effective way to gain exposure to mid-cap stocks. With an expense ratio of just 0.09%, BRMIX is an attractive option for those seeking growth opportunities within the mid-cap space. The fund’s objective is to provide growth by investing in a diversified portfolio of mid-cap companies, making it suitable for investors looking to capitalize on the potential of mid-sized firms in the U.S. market.
At A Glance
Executive Summary
BRMIX offers low-cost exposure to US mid-cap stocks with a 0.09% expense ratio, ideal for growth-focused investors seeking mid-cap market exposure.
Low expense ratio of 0.09% enhances cost efficiency. Strong 1-year return of 37.44% indicates robust performance. Diverse sector allocation supports growth potential.
Negative alpha of -0.22% suggests underperformance against benchmark. Sharpe Ratio of -0.02 indicates low risk-adjusted returns. Max drawdown of -6.5% may concern risk-averse investors.
Performance Analysis: A Year of Strong Returns
BRMIX has demonstrated impressive performance over the past year, with a 1-year return of 37.44%, closely aligning with its benchmark, the S&P 500 Total Return Index, which returned 37.62%. This strong performance highlights the fund’s ability to capture growth in the mid-cap sector, making it a compelling choice for growth-oriented investors. Despite a negative alpha of -0.22%, indicating slight underperformance relative to its benchmark, the fund’s beta of 0.96 suggests it has been less volatile than the market, providing a stable investment option within the mid-cap category.
Sector Allocation: A Balanced Approach to Growth
The sector allocation of BRMIX is well-diversified, with significant investments in technology (16.32%), industrials (15.97%), and financials (13.98%). This balanced approach allows the fund to capitalize on growth opportunities across various sectors, reducing the risk associated with over-concentration in a single industry. The fund’s exposure to technology and industrials is particularly noteworthy, as these sectors have been key drivers of growth in the mid-cap space. Additionally, the fund’s allocation to real estate (8.30%) and health care (10.35%) provides further diversification, enhancing its potential for stable returns.
Risk Metrics: Understanding the Fund’s Volatility
BRMIX exhibits a beta of 0.96, indicating that it is slightly less volatile than the overall market. However, the fund’s Sharpe Ratio of -0.02 and Treynor Ratio of -0.23 suggest that its risk-adjusted returns have been relatively low. The fund’s standard deviation of 3.93% reflects moderate volatility, while its downside risk (UI) of 2.31% indicates a potential for loss in adverse market conditions. Investors should also consider the fund’s max drawdown of -6.5%, which occurred over a short period, highlighting the importance of understanding the fund’s risk profile before investing.
Competitive Comparison: How BRMIX Stacks Up
When compared to similar funds, BRMIX holds its ground with a competitive expense ratio of 0.09%, which is lower than many of its peers. For instance, the Schwab US MidCap IxFd (SWMCX) and Fidelity Flex MidCap Index Fd (FLAPX) have slightly higher expense ratios, while the Fidelity MidCap Growth Index Fd (FMDGX) offers a higher 1-year return of 43.87%. Despite this, BRMIX’s strong performance and cost efficiency make it a viable option for investors seeking mid-cap exposure. The fund’s yield of 1.44% also compares favorably with its peers, providing an additional income stream for investors.
Top Holdings: Key Contributors to Performance
BRMIX’s top holdings include iShares Russell Mid-Cap ETF (IWR), Palantir Technologies Inc (PLTR), and Aflac Inc (AFL), which together represent a small but significant portion of the fund’s portfolio. These companies are leaders in their respective industries, contributing to the fund’s overall performance. The inclusion of technology firms like Palantir highlights the fund’s focus on growth sectors, while holdings in financial and industrial companies like Aflac and Arthur J. Gallagher & Co (AJG) provide stability and diversification. This strategic selection of holdings supports the fund’s growth objective and enhances its potential for long-term capital appreciation.
Market Cap Allocation: Focus on Medium-Sized Firms
The market cap allocation of BRMIX is heavily weighted towards medium-sized firms, with 77.67% of its assets invested in this category. This focus on mid-cap companies aligns with the fund’s objective of capturing growth opportunities in the mid-cap sector. The fund also maintains a smaller allocation to small-cap (18.37%) and large-cap (2.66%) stocks, providing a balanced approach to market capitalization. This strategy allows the fund to benefit from the growth potential of mid-sized companies while maintaining some exposure to smaller and larger firms, enhancing its overall diversification and risk management.
Conclusion: Is BRMIX Right for Your Portfolio?
BRMIX stands out as a strong contender for investors seeking growth within the mid-cap sector. Its low expense ratio, impressive 1-year return, and diversified sector allocation make it an attractive option for those looking to capitalize on the potential of mid-sized U.S. companies. However, investors should be mindful of the fund’s risk metrics, including its negative alpha and low risk-adjusted returns. Overall, BRMIX is well-suited for growth-oriented investors who are comfortable with moderate volatility and are seeking a cost-effective way to gain exposure to the mid-cap market.
Similar Securities
BSDAX: BlackRock Small/MidCap Growth Fund | High-Growth U.S. Equities
BSDAX offers exposure to high-growth U.S. small/mid-cap stocks with a focus on above-average earnings potential, despite higher volatility.
MASPX: BlackRock Advantage Small/MidCap-Inst | High Growth Potential
MASPX offers a competitive 38.71% 1-year return with a low 0.48% expense ratio, focusing on small to mid-cap equities for growth.
TQSAX: TRPrice Integrated US SMCap Core Eq-Adv | Small/Mid-Cap Growth Fund
TQSAX offers robust growth with a 42.49% 1-year return, focusing on small/mid-cap U.S. equities. High alpha and sector diversity enhance its appeal.
PMEGX: TRPrice Inst MidCap Equity Growth-Inst | Mid-Cap Growth Investment
PMEGX offers mid-cap growth with a 0.61% expense ratio, focusing on stocks with high earnings potential. Strong 1-year return of 29.07%.
LBGAX: ClearBridge MidCap Growth-A | MidCap Growth Investment
LBGAX offers a robust 39.67% 1-year return with a focus on mid-cap equities, outperforming its benchmark with a 2.00% alpha.
Futher Reading
https://finance.yahoo.com/quote/BRMIX/”>Yahoo: iShares Russell MidCap IxFd-Inst
Disclaimer: The information provided on this website is for informational purposes only and should not be construed as financial, investment, or other professional advice. PeepFinance does not endorse or recommend any specific securities, investments, or strategies. The opinions expressed are solely those of the authors and are not intended to be used as the basis for any investment decisions. All investments carry risks, and readers are encouraged to conduct their own research or consult with a financial professional before making any financial decisions. PeepFinance and its authors are not responsible for any losses or damages arising from the use of this information.